Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Peripheral Vasodilator Drugs Market Report 2025

Peripheral Vasodilator Drugs Global Market Report 2025 – By Drug Type (Calcium Channel Blockers, Direct-Acting Vasodilators, Alpha-Adrenergic Blockers, Potassium Channel Activators, Nitrates, Other Types), By Indication (Hypertension, Angina, Heart Failure, Other Indications), By Application (Hospital, Retail Pharmacies, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Peripheral Vasodilator Drugs Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Peripheral Vasodilator Drugs Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Peripheral Vasodilator Drugs Market Definition

Peripheral vasodilator drugs refer to medications that primarily act on blood vessels outside of the heart and brain, specifically targeting the peripheral circulation. These drugs are used to widen (dilate) blood vessels, thereby reducing resistance to blood flow and lowering blood pressure.

The main types of peripheral vasodilator drugs include calcium channel blockers, direct-acting vasodilators, alpha-adrenergic blockers, potassium channel activators, nitrates, and others. Calcium channel blockers are medications that relax and widen blood vessels by inhibiting calcium from entering the cells of the heart and arterial wall and helps reduce blood pressure and improve blood flow. The indications include Hypertension, Angina, heart failure, and others for application in hospitals, retail pharmacies, and others.

Peripheral Vasodilator Drugs Market Segmentation

The peripheral vasodilator drugs market covered in this report is segmented –

1) By Drug Type: Calcium Channel Blockers, Direct-Acting Vasodilators, Alpha-Adrenergic Blockers, Potassium Channel Activators, Nitrates, Other Types

2) By Indication: Hypertension, Angina, Heart Failure, Other Indications

3) By Application: Hospital, Retail Pharmacies, Other Applications

Subsegments:

1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines

2) By Direct-Acting Vasodilators: Hydralazine, Minoxidil, Nitroprusside

3) By Alpha-Adrenergic Blockers: Prazosin, Doxazosin, Terazosin

4) By Potassium Channel Activators: Nicorandil, Diazoxide

5) By Nitrates: Nitroglycerin, Isosorbide Dinitrate, Isosorbide Mononitrate

6) By Other Types: Phosphodiesterase Inhibitors, Endothelin Receptor Antagonists

Peripheral Vasodilator Drugs Market Size and growth rate 2025 to 2029: Graph

Peripheral Vasodilator Drugs Market Size 2025 And Growth Rate

The peripheral vasodilator drugs market size has grown strongly in recent years. It will grow from $6.27 billion in 2024 to $6.67 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, and growing patient preference for non-surgical or minimally invasive treatment options.

Peripheral Vasodilator Drugs Market Growth Forecast

The peripheral vasodilator drugs market size is expected to see strong growth in the next few years. It will grow to $8.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, and timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increased collaboration, real-world evidence, gene therapy, preventive interventions, and value-based healthcare.

Book your 30 minutes free consultation with our research experts

Contact Us

Peripheral Vasodilator Drugs Market Driver: Rising Cardiovascular Disease Prevalence Fuels Growth in Peripheral Vasodilator Drugs Market

An increase in the prevalence of cardiovascular diseases is expected to propel the growth of the peripheral vasodilator drug market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, often caused by atherosclerosis, leading to conditions like heart attacks, strokes, hypertension, and heart failure. The cases of cardiovascular diseases arise primarily due to sedentary lifestyles, unhealthy diets, aging populations, rising rates of obesity, and related health conditions such as diabetes and hypertension. Peripheral vasodilators in cardiovascular diseases improve blood flow, reduce blood pressure, decrease the heart’s workload, and alleviate symptoms of conditions such as peripheral arterial disease. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, doctor-certified deaths from coronary heart disease (CHD) rose to 14,100 in 2021 and increased further to 14,900 in 2022. Therefore, the increase in the prevalence of cardiovascular diseases is driving the growth of the peripheral vasodilator drug market.

Global Peripheral Vasodilator Drugs Market Major Players

Major companies operating in the peripheral vasodilator drugs market are Pfizer Inc., Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Takeda Pharmaceutical Company, Gilead Sciences Inc, Amgen Inc, Boehringer Ingelheim International GmbH, Merck & Co, Viatris Inc., Baxter, Teva Pharmaceutical Industries, Astellas Pharma, Daiichi Sankyo Company, Limited, Sun Pharmaceutical Industries, Mitsubishi Tanabe Pharma, Cipla Limited, Hikma Pharmaceuticals, Lupin Pharmaceuticals, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Ipca Laboratories, Alembic Pharmaceuticals

Global Peripheral Vasodilator Drugs Market Trend: Innovation In Peripheral Vasodilator Market With Advanced Drug Development

Major companies operating in the peripheral vasodilator drugs market are focusing on drug development with triple-drug combination therapies to optimize treatment outcomes and expand market share in cardiovascular therapeutics. Triple-drug combination therapy is an antihypertensive FDC that targets patients who have not achieved adequate blood pressure control with dual-drug therapies or are unable to tolerate diuretic-based combinations. For instance, in August 2023, Ajanta Pharma Limited, an India-based pharmaceutical company specializing in cardiology, introduced Met XL AMT, a novel triple-drug combination to manage hypertension among Indian patients. It is a fixed-dose combination (FDC) of three antihypertensive agents, including Telmisartan, Amlodipine, and Metoprolol. These agents work together to lower blood pressure by relaxing blood vessels, which is a characteristic of peripheral vasodilators. The drug is specifically approved by DCGI for managing uncontrolled hypertension alongside stable coronary artery disease, making IT the world's first fixed-dose combination (FDC) of metoprolol succinate (extended-release) 50 mg, amlodipine 5 mg, and telmisartan 40 mg.

Peripheral Vasodilator Drugs Market Merger And Acquisition: Advent International Acquires Mexico- And Brazil-Based Pharmaceutical Businesses From Perrigo Company Plc

In March 2022, Advent International Corporation, a US-based private equity investor company, acquired Mexico- and Brazil pharmaceutical businesses from Perrigo Company plc for an undisclosed amount. Through this acquisition, Advent enhances its regional investment strategy within the pharmaceutical sector, leveraging over two decades of industry experience to further strengthen its position in the market. Perrigo Company plc is an Ireland-based pharmaceutical and health and wellness drug manufacturer that manufactures vasodilators such as nitroglycerin for hypertension.

Regional Outlook For The Global Peripheral Vasodilator Drugs Market

North America was the largest region in the peripheral vasodilator drugs market in 2024. The regions covered in the peripheral vasodilator drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the peripheral vasodilator drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Peripheral Vasodilator Drugs Market?

The peripheral vasodilator drugs market consists of sales of angiotensin II receptor blockers (ARBs), nitric oxide donors, direct renin inhibitors, and endothelin receptor antagonists. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Peripheral Vasodilator Drugs Industry?

The peripheral vasodilator drugs market research report is one of a series of new reports from the business research company that provides peripheral vasodilator drugs market statistics, including peripheral vasodilator drugs industry global market size, regional shares, competitors with an peripheral vasodilator drugs market share, detailed peripheral vasodilator drugs market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral vasodilator drugs industry. This peripheral vasodilator drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Peripheral Vasodilator Drugs Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $6.67 billion
Revenue Forecast In 2034 $8.44 billion
Growth Rate CAGR of 6.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Calcium Channel Blockers, Direct-Acting Vasodilators, Alpha-Adrenergic Blockers, Potassium Channel Activators, Nitrates, Other Types
2) By Indication: Hypertension, Angina, Heart Failure, Other Indications
3) By Application: Hospital, Retail Pharmacies, Other Applications Subsegments: 1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Direct-Acting Vasodilators: Hydralazine, Minoxidil, Nitroprusside
3) By Alpha-Adrenergic Blockers: Prazosin, Doxazosin, Terazosin
4) By Potassium Channel Activators: Nicorandil, Diazoxide
5) By Nitrates: Nitroglycerin, Isosorbide Dinitrate, Isosorbide Mononitrate 6) By Other Types: Phosphodiesterase Inhibitors, Endothelin Receptor Antagonists
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Takeda Pharmaceutical Company, Gilead Sciences Inc, Amgen Inc, Boehringer Ingelheim International GmbH, Merck & Co, Viatris Inc., Baxter, Teva Pharmaceutical Industries, Astellas Pharma, Daiichi Sankyo Company, Limited, Sun Pharmaceutical Industries, Mitsubishi Tanabe Pharma, Cipla Limited, Hikma Pharmaceuticals, Lupin Pharmaceuticals, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Ipca Laboratories, Alembic Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Peripheral Vasodilator Drugs Market Characteristics

    3. Peripheral Vasodilator Drugs Market Trends And Strategies

    4. Peripheral Vasodilator Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Peripheral Vasodilator Drugs Growth Analysis And Strategic Analysis Framework

    5.1. Global Peripheral Vasodilator Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Peripheral Vasodilator Drugs Market Growth Rate Analysis

    5.4. Global Peripheral Vasodilator Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Peripheral Vasodilator Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Peripheral Vasodilator Drugs Total Addressable Market (TAM)

    6. Peripheral Vasodilator Drugs Market Segmentation

    6.1. Global Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Calcium Channel Blockers

    Direct-Acting Vasodilators

    Alpha-Adrenergic Blockers

    Potassium Channel Activators

    Nitrates

    Other Types

    6.2. Global Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hypertension

    Angina

    Heart Failure

    Other Indications

    6.3. Global Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital

    Retail Pharmacies

    Other Applications

    6.4. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Dihydropyridines

    Non-Dihydropyridines

    6.5. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Direct-Acting Vasodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hydralazine

    Minoxidil

    Nitroprusside

    6.6. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Alpha-Adrenergic Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Prazosin

    Doxazosin

    Terazosin

    6.7. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Potassium Channel Activators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Nicorandil

    Diazoxide

    6.8. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Nitroglycerin

    Isosorbide Dinitrate

    Isosorbide Mononitrate

    6.9. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Phosphodiesterase Inhibitors

    Endothelin Receptor Antagonists

    7. Peripheral Vasodilator Drugs Market Regional And Country Analysis

    7.1. Global Peripheral Vasodilator Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Peripheral Vasodilator Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Peripheral Vasodilator Drugs Market

    8.1. Asia-Pacific Peripheral Vasodilator Drugs Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Peripheral Vasodilator Drugs Market

    9.1. China Peripheral Vasodilator Drugs Market Overview

    9.2. China Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Peripheral Vasodilator Drugs Market

    10.1. India Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Peripheral Vasodilator Drugs Market

    11.1. Japan Peripheral Vasodilator Drugs Market Overview

    11.2. Japan Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Peripheral Vasodilator Drugs Market

    12.1. Australia Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Peripheral Vasodilator Drugs Market

    13.1. Indonesia Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Peripheral Vasodilator Drugs Market

    14.1. South Korea Peripheral Vasodilator Drugs Market Overview

    14.2. South Korea Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Peripheral Vasodilator Drugs Market

    15.1. Western Europe Peripheral Vasodilator Drugs Market Overview

    15.2. Western Europe Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Peripheral Vasodilator Drugs Market

    16.1. UK Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Peripheral Vasodilator Drugs Market

    17.1. Germany Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Peripheral Vasodilator Drugs Market

    18.1. France Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Peripheral Vasodilator Drugs Market

    19.1. Italy Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Peripheral Vasodilator Drugs Market

    20.1. Spain Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Peripheral Vasodilator Drugs Market

    21.1. Eastern Europe Peripheral Vasodilator Drugs Market Overview

    21.2. Eastern Europe Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Peripheral Vasodilator Drugs Market

    22.1. Russia Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Peripheral Vasodilator Drugs Market

    23.1. North America Peripheral Vasodilator Drugs Market Overview

    23.2. North America Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Peripheral Vasodilator Drugs Market

    24.1. USA Peripheral Vasodilator Drugs Market Overview

    24.2. USA Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Peripheral Vasodilator Drugs Market

    25.1. Canada Peripheral Vasodilator Drugs Market Overview

    25.2. Canada Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Peripheral Vasodilator Drugs Market

    26.1. South America Peripheral Vasodilator Drugs Market Overview

    26.2. South America Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Peripheral Vasodilator Drugs Market

    27.1. Brazil Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Peripheral Vasodilator Drugs Market

    28.1. Middle East Peripheral Vasodilator Drugs Market Overview

    28.2. Middle East Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Peripheral Vasodilator Drugs Market

    29.1. Africa Peripheral Vasodilator Drugs Market Overview

    29.2. Africa Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Peripheral Vasodilator Drugs Market Competitive Landscape And Company Profiles

    30.1. Peripheral Vasodilator Drugs Market Competitive Landscape

    30.2. Peripheral Vasodilator Drugs Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

    31. Peripheral Vasodilator Drugs Market Other Major And Innovative Companies

    31.1. Abbott Laboratories

    31.2. Novartis AG

    31.3. GSK plc

    31.4. Takeda Pharmaceutical Company

    31.5. Gilead Sciences Inc

    31.6. Amgen Inc

    31.7. Boehringer Ingelheim International GmbH

    31.8. Merck & Co

    31.9. Viatris Inc.

    31.10. Baxter

    31.11. Teva Pharmaceutical Industries

    31.12. Astellas Pharma

    31.13. Daiichi Sankyo Company, Limited

    31.14. Sun Pharmaceutical Industries

    31.15. Mitsubishi Tanabe Pharma

    32. Global Peripheral Vasodilator Drugs Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Peripheral Vasodilator Drugs Market

    34. Recent Developments In The Peripheral Vasodilator Drugs Market

    35. Peripheral Vasodilator Drugs Market High Potential Countries, Segments and Strategies

    35.1 Peripheral Vasodilator Drugs Market In 2029 - Countries Offering Most New Opportunities

    35.2 Peripheral Vasodilator Drugs Market In 2029 - Segments Offering Most New Opportunities

    35.3 Peripheral Vasodilator Drugs Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Direct-Acting Vasodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Alpha-Adrenergic Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Potassium Channel Activators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Peripheral Vasodilator Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Peripheral Vasodilator Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Bayer AG Financial Performance
  • Table 82: Sanofi S.A. Financial Performance
  • Table 83: Thermo Fisher Scientific Inc. Financial Performance
  • Table 84: AstraZeneca PLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Direct-Acting Vasodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Alpha-Adrenergic Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Potassium Channel Activators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Peripheral Vasodilator Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Peripheral Vasodilator Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Bayer AG Financial Performance
  • Figure 82: Sanofi S.A. Financial Performance
  • Figure 83: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 84: AstraZeneca PLC Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth

Read More

Extended Reality Market 2024 – By Component (Hardware, Software, Services), By Technologies (Augmented Reality (AR) Technology, Virtual Reality (VR) Technology, Mixed Reality (MR) Technology), By End-User (Gaming, Retail, Healthcare, Engineering, Media And Entertainment, Real Estate, Other End-User), And By Region, Opportunities And Strategies – Global Forecast To 2033

View Report

Homeware Global Market Report 2025 – By Product Type (Home Decoration, Furniture, Soft Furnishings, Kitchenware, Home Appliances, Lighting, Storage And Flooring, Bathroom Accessories And Cleaning, Tableware And Hardware Tools, Other Products), By Application (Residential, Commercial), By Distributional Channel (Homeware Stores, Franchised Stores, Departmental Stores, Online Stores, Specialty Stores) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Automotive Camera Global Market Report 2025 – By Vehicle Type (Passenger Vehicle, Light Commercial Vehicle, Heavy Commercial Vehicle), By View Type (Single View System, Multi Camera System), By Technology (Digital Cameras, Infrared Cameras, Thermal Cameras), By Application (Park Assist, Advanced Driver-Assistance Systems) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gas Engines Global Market Report 2025 – By Fuel Type (Natural Gas, Special Gas, Other Fuel Type), By Power Output (1-2 MW, 2-5 MW, 5-15 MW, Above 15 MW), By Application (Power Generation, Mechanical Drive, Cogenerations, Other Applications), By End User (Utilities, Marine, Oil And Gas, Manufacturing, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Smart Biopsy Devices Global Market Report 2025 – By Product (Needle-Based Biopsy Instruments, Procedure trays, Localization Wires, Other Products), By Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques), By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications), By End-User (Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Electron Microscopy And Sample Preparation Global Market Report 2025 – By Product (Microscopes, Software, Other Products), By Application (Semiconductors, Life Sciences, Material Sciences, Other Applications), By End-user (Industries, Academic And Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Wrapping Machine Global Market Report 2025 – By Type (Stretch, Shrink, Other Types), By Mode Of Operation (Semi-Automatic Wrapping Machine, Automatic Wrapping Machine), By Application (Food Industry, Beverages Industry, Personal Care, Pharmaceuticals, Chemicals, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Peripheral Vasodilator Drugs market?

Peripheral vasodilator drugs refer to medications that primarily act on blood vessels outside of the heart and brain, specifically targeting the peripheral circulation. These drugs are used to widen (dilate) blood vessels, thereby reducing resistance to blood flow and lowering blood pressure. For further insights on the Peripheral Vasodilator Drugs market, request a sample here

How will the Peripheral Vasodilator Drugs market drivers and restraints affect the market dynamics? What forces will shape the Peripheral Vasodilator Drugs industry going forward?

The Peripheral Vasodilator Drugs market major growth driver - Rising Cardiovascular Disease Prevalence Fuels Growth in Peripheral Vasodilator Drugs Market. For further insights on the Peripheral Vasodilator Drugs market, request a sample here

What is the forecast market size or the forecast market value of the Peripheral Vasodilator Drugs market?

The Peripheral Vasodilator Drugs market size has grown strongly in recent years. The peripheral vasodilator drugs market size has grown strongly in recent years. It will grow from $6.27 billion in 2024 to $6.67 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, and growing patient preference for non-surgical or minimally invasive treatment options. The peripheral vasodilator drugs market size is expected to see strong growth in the next few years. It will grow to $8.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, and timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increased collaboration, real-world evidence, gene therapy, preventive interventions, and value-based healthcare. For further insights on the Peripheral Vasodilator Drugs market, request a sample here

How is the Peripheral Vasodilator Drugs market segmented?

The peripheral vasodilator drugs market covered in this report is segmented –
1) By Drug Type: Calcium Channel Blockers, Direct-Acting Vasodilators, Alpha-Adrenergic Blockers, Potassium Channel Activators, Nitrates, Other Types
2) By Indication: Hypertension, Angina, Heart Failure, Other Indications
3) By Application: Hospital, Retail Pharmacies, Other Applications
Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Direct-Acting Vasodilators: Hydralazine, Minoxidil, Nitroprusside
3) By Alpha-Adrenergic Blockers: Prazosin, Doxazosin, Terazosin
4) By Potassium Channel Activators: Nicorandil, Diazoxide
5) By Nitrates: Nitroglycerin, Isosorbide Dinitrate, Isosorbide Mononitrate
6) By Other Types: Phosphodiesterase Inhibitors, Endothelin Receptor Antagonists For further insights on the Peripheral Vasodilator Drugs market, request a sample here

Which region has the largest share of the Peripheral Vasodilator Drugs market? What are the other regions covered in the report?

North America was the largest region in the peripheral vasodilator drugs market in 2024. The regions covered in the peripheral vasodilator drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Peripheral Vasodilator Drugs market, request a sample here.

Who are the major players in the Peripheral Vasodilator Drugs market?

Major companies operating in the peripheral vasodilator drugs market are focusing on drug development with triple-drug combination therapies to optimize treatment outcomes and expand market share in cardiovascular therapeutics. Triple-drug combination therapy is an antihypertensive FDC that targets patients who have not achieved adequate blood pressure control with dual-drug therapies or are unable to tolerate diuretic-based combinations. For instance, in August 2023, Ajanta Pharma Limited, an India-based pharmaceutical company specializing in cardiology, introduced Met XL AMT, a novel triple-drug combination to manage hypertension among Indian patients. It is a fixed-dose combination (FDC) of three antihypertensive agents, including Telmisartan, Amlodipine, and Metoprolol. These agents work together to lower blood pressure by relaxing blood vessels, which is a characteristic of peripheral vasodilators. The drug is specifically approved by DCGI for managing uncontrolled hypertension alongside stable coronary artery disease, making it the world's first fixed-dose combination (FDC) of metoprolol succinate (extended-release) 50 mg, amlodipine 5 mg, and telmisartan 40 mg.. For further insights on the Peripheral Vasodilator Drugs market, request a sample here.

What are the key trends in the Peripheral Vasodilator Drugs market?

Major trends in the Peripheral Vasodilator Drugs market include Innovation In Peripheral Vasodilator Market With Advanced Drug Development. For further insights on the Peripheral Vasodilator Drugs market, request a sample here.

What are the major opportunities in the Peripheral Vasodilator Drugs market? What are the strategies for the Peripheral Vasodilator Drugs market?

For detailed insights on the major opportunities and strategies in the Peripheral Vasodilator Drugs market, request a sample here.

How does the Peripheral Vasodilator Drugs market relate to the overall economy and other similar markets?

For detailed insights on Peripheral Vasodilator Drugs's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Peripheral Vasodilator Drugs industry?

For detailed insights on the mergers and acquisitions in the Peripheral Vasodilator Drugs industry, request a sample here.

What are the key dynamics influencing the Peripheral Vasodilator Drugs market growth? SWOT analysis of the Peripheral Vasodilator Drugs market.

For detailed insights on the key dynamics influencing the Peripheral Vasodilator Drugs market growth and SWOT analysis of the Peripheral Vasodilator Drugs industry, request a sample here.